-+ 0.00%
-+ 0.00%
-+ 0.00%

Nightingale Health, Archipelago Health to Launch Blood Test in Small-island Jurisdictions

MT Newswires·09/23/2026 05:55:20
Listen to the news
05:55 AM EDT, 09/23/2026 (MT Newswires) -- Nightingale Health (HEALTH.HE) and Archipelago Health agreed to roll out the Finnish health technology company's blood-based risk detection test to small-island healthcare systems in the Crown Dependencies, Bermuda, and the Caribbean. The deal follows a letter of intent signed in July, according to a Wednesday release. It aims to deliver the Nightingale Health Check, which detects major chronic disease risks, to local primary care services through Archipelago's Longitude brand, with Nightingale to analyze all samples. Initial live testing is set for November in Jersey, a British Crown Dependency.